News

Dallas-Ronald A. Schachar, MD, the founder and chairman of Presby Corp., has resigned as director, officer, and employee of the company, which is now known as Refocus Group Inc. Dr. Schachar's resignation occurred as the medical device company moved to expand its board of directors.

Dallas-TransFirst Health Services is offering credit card transaction processing for more than 8,000 members of the American Society of Cataract and Refractive Surgery (ASCRS) and the American Society of Ophthalmic Administrators (ASOA).

Mountain View, CA-California's Medicare Part B carrier will begin to cover transpupillary thermotherapy (TTT) and feeder vessel (FV) laser protocols to treat wet age-related macular degeneration (AMD).

Santa Ana, CA-Advanced Medical Optics (AMO) Inc. has secured distribution rights for a capsular tension ring, manufactured by OPHTEC BV, that is said to ensure capsular bag stability.

Hunting for Larry W. Kreider, MD, ophthalmologist, is more than just a sport. Since he began hunting with his father and grandfather at 12 years old, he has made memories and learned lessons that he will never forget.

San Francisco-The newest version (A2) of the Carl Zeiss Meditec software algorithm for quantification of retinal nerve fiber layer (RNFL) thickness using the third-generation optical coherence tomography (OCT 3) showed no improvement in glaucoma discriminating power compared with its predecessor software (A1), but it did reduce the variability of RNFL thickness measurements, according to a Tufts University glaucoma specialist.

Orlando-Adjustment for energy delivery calibration errors represents the single most important step excimer laser manufacturers can take toward achieving improved visual outcomes in eyes undergoing corneal ablative refractive surgery, said Jack T. Holladay, MD, MSEE, FACS, at the annual meeting of the American College of Surgeons.

Dallas-Moxifloxacin ophthalmic solution (Vigamox 0.5%, Alcon Laboratories) was approved by the FDA on April 16 for the treatment of bacterial conjunctivitis, following a 6-month review of the drug.

San Francisco-With the presbyopic population reaching 51% (141 million) in the United States, the interest in surgical correction of presbyopia will likely take off as the baby boomers look for alternatives to glasses, according to Richard L. Lindstrom, MD, who delivered the Binkhorst Lecture during the opening session of the American Society of Cataract and Refractive Surgery annual meeting.

San Francisco-Nearly 100,000 people in the United States are blind from glaucoma, and this number will rise enormously as the population ages over the next 20 years unless better detection and treatment methods are developed, said Nathan G. Congdon, MD, MPH.

Editor's Note: Anterior uveitis is the most common type of intraocular inflammation. Among patients with inflammation localized primarily to the anterior chamber, 50% or more are HLA-B27 positive. Inaddition, a number of these patients with HLA-B27-associated anterior uveitis have, or will develop, an associated systemicdisorder such as ankylosing spondylitis,reactive arthritis (formerly known asReiter's syndrome), inflammatory bowel disease, or psoriatic arthritis.

Cleveland-A protein produced by the body might help prevent abnormal blood vessel growth and treat diseases such as wet age-related macular degeneration, diabetic retinopathy, and cancer.

Washington, DC-The Centers for Medicare and Medicaid Services (CMS) has expanded the list of procedures it will cover, including several important ophthalmic procedures.

The FDA is looking for more analysis of data before deciding whether to approve ISTA Pharmaceuticals' ovine hyaluronidase compound for the treatment of vitreous hemorrhage.